{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:25:36Z","timestamp":1790943936256,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.expneurol.2007.10.015","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T06:05:36Z","timestamp":1196489136000},"page":"154-163","source":"Crossref","is-referenced-by-count":154,"title":["The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington's disease mouse model"],"prefix":"10.1016","volume":"210","author":[{"given":"Qi","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.expneurol.2007.10.015_bib1","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1089\/10430349950016393","article-title":"Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer","volume":"10","author":"Bemelmans","year":"1999","journal-title":"Hum. Gene Ther"},{"issue":"35","key":"10.1016\/j.expneurol.2007.10.015_bib3","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci"},{"issue":"6","key":"10.1016\/j.expneurol.2007.10.015_bib4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jnr.20344","article-title":"Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF","volume":"78","author":"Cepeda","year":"2004","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.expneurol.2007.10.015_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","article-title":"Transcriptional dysregulation in Huntington's disease","volume":"23","author":"Cha","year":"2000","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.expneurol.2007.10.015_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.b.30501","article-title":"Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients","volume":"144","author":"Ciammola","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr Genet"},{"issue":"4","key":"10.1016\/j.expneurol.2007.10.015_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.b.30501","article-title":"Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients","volume":"144","author":"Ciammola","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet"},{"key":"10.1016\/j.expneurol.2007.10.015_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0166-2236(02)02143-4","article-title":"Exercise: a behavioral intervention to enhance brain health and plasticity","volume":"25","author":"Cotman","year":"2002","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.expneurol.2007.10.015_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0070-2153(06)75002-5","article-title":"Selective neuronal degeneration in Huntington's disease","volume":"75","author":"Cowan","year":"2006","journal-title":"Curr. Top. Dev. Biol"},{"key":"10.1016\/j.expneurol.2007.10.015_bib9","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1073\/pnas.1532244100","article-title":"Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain","volume":"100","author":"Curtis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2007.10.015_bib10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1440-1681.2007.04609.x","article-title":"Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia","volume":"34","author":"Curtis","year":"2007","journal-title":"Clin. Exp. Pharmacol Physiol"},{"key":"10.1016\/j.expneurol.2007.10.015_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuroimage.2005.01.039","article-title":"Magnetic resonance imaging at microscopic resolution reveals subtle morphological changes in a mouse model of dopaminergic hyperfunction","volume":"26","author":"Cyr","year":"2005","journal-title":"NeuroImage"},{"key":"10.1016\/j.expneurol.2007.10.015_bib12","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intracellular inclusions and dystrophic neuritis in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2007.10.015_bib13","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"100","author":"Duan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2007.10.015_bib14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.20075","article-title":"Paroxetine retards disease onset and progression in Huntingtin mutant mice","volume":"55","author":"Duan","year":"2004","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.expneurol.2007.10.015_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0006-3223(98)00031-6","article-title":"Novel therapeutic approaches beyond the serotonin receptor","volume":"44","author":"Duman","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2007.10.015_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1385\/NMM:5:1:011","article-title":"Role of neurotrophic factors in the etiology and treatment of mood disorders","volume":"5","author":"Duman","year":"2004","journal-title":"Neuromolecular Med"},{"issue":"12","key":"10.1016\/j.expneurol.2007.10.015_bib17","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"1-2","key":"10.1016\/j.expneurol.2007.10.015_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","article-title":"Brain-derived neurotrophic factor in Huntington disease","volume":"866","author":"Ferrer","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2007.10.015_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0896-6273(00)81132-0","article-title":"Polyglutamine expansions: proteolysis, chaperones, and the dangers of promiscuity","volume":"26","author":"Ferrigno","year":"2000","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.expneurol.2007.10.015_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2007.10.015_bib22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","article-title":"Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington's disease mice","volume":"20","author":"Gil","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.expneurol.2007.10.015_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0006-8993(02)02505-2","article-title":"Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro","volume":"941","author":"Goggi","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2007.10.015_bib24","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1016\/j.expneurol.2007.10.015_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","article-title":"Environmental enrichment slows disease progression in R6\/2 Huntington's disease mice","volume":"51","author":"Hockly","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.expneurol.2007.10.015_bib27","doi-asserted-by":"crossref","first-page":"18189","DOI":"10.1073\/pnas.0506375102","article-title":"FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease","volume":"102","author":"Jin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"5","key":"10.1016\/j.expneurol.2007.10.015_bib28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ymthe.2004.02.016","article-title":"AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease","volume":"9","author":"Kells","year":"2004","journal-title":"Mol Ther."},{"issue":"3","key":"10.1016\/j.expneurol.2007.10.015_bib29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410220318","article-title":"Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum","volume":"22","author":"Kish","year":"1987","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.expneurol.2007.10.015_bib30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00001756-200404090-00014","article-title":"Decreased hippocampal cell proliferation in R6\/1 Huntington's mice","volume":"15","author":"Lazic","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2007.10.015_bib31","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1046\/j.1471-4159.2002.01085.x","article-title":"Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice","volume":"82","author":"Lee","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.expneurol.2007.10.015_bib32","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation, J","volume":"19","author":"Lione","year":"1999","journal-title":"Neurosci"},{"issue":"16","key":"10.1016\/j.expneurol.2007.10.015_bib33","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease","volume":"27","author":"Lynch","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.10.015_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tips.2005.10.005","article-title":"Antidepressant action: to the nucleus and beyond","volume":"26","author":"Malberg","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.expneurol.2007.10.015_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.arr.2004.08.001","article-title":"A neural signaling triumvirate that influences ageing and age-related disease: insulin\/IGF-1, BDNF and serotonin","volume":"3","author":"Mattson","year":"2004","journal-title":"Ageing Res Rev"},{"issue":"13","key":"10.1016\/j.expneurol.2007.10.015_bib36","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.expneurol.2007.10.015_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.38.3.341","article-title":"Clinical and neuropathologic assessment of severity in Huntington's disease","volume":"38","author":"Myers","year":"1988","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.expneurol.2007.10.015_bib38","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF02704114","article-title":"Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood?","volume":"31","author":"Nair","year":"2006","journal-title":"J Biosci"},{"issue":"11","key":"10.1016\/j.expneurol.2007.10.015_bib39","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.expneurol.2007.10.015_bib40","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","article-title":"Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus","volume":"16","author":"Nibuya","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.expneurol.2007.10.015_bib41","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/01.wnr.0000236855.85962.f6","article-title":"Limbic neurogenesis\/plasticity in the R6\/2 mouse model of Huntington's disease","volume":"17","author":"Phillips","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2007.10.015_bib42","doi-asserted-by":"crossref","first-page":"11564","DOI":"10.1523\/JNEUROSCI.3796-05.2005","article-title":"Abnormalities of neurogenesis in the R6\/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment","volume":"25","author":"Phillips","year":"2005","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.expneurol.2007.10.015_bib43","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1471-4159.2005.03047.x","article-title":"Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease","volume":"93","author":"Pineda","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.expneurol.2007.10.015_bib44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1176\/jnp.8.3.338","article-title":"Sertraline in the treatment of severe aggressiveness in Huntington's disease","volume":"8","author":"Ranen","year":"1996","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.expneurol.2007.10.015_bib45","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"78(2)","key":"10.1016\/j.expneurol.2007.10.015_bib46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0304-3940(87)90639-2","article-title":"Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain","volume":"22","author":"Reynolds","year":"1987","journal-title":"Neurosci Lett."},{"key":"10.1016\/j.expneurol.2007.10.015_bib47","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1046\/j.1471-4159.1999.721773.x","article-title":"Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation","volume":"72","author":"Reynolds","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.expneurol.2007.10.015_bib48","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat Med."},{"key":"10.1016\/j.expneurol.2007.10.015_bib49","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrm1742","article-title":"Opinion: What is the role of protein aggregation in neurodegeneration?","volume":"6","author":"Ross","year":"2005","journal-title":"Nat. Rev. Mol. Cell Bio"},{"issue":"2","key":"10.1016\/j.expneurol.2007.10.015_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/scnp.2003.50014","article-title":"Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders","volume":"8","author":"Russo-Neustadt","year":"2003","journal-title":"Semin Clin Neuropsychiatry"},{"issue":"5-6","key":"10.1016\/j.expneurol.2007.10.015_bib51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/FBP.0b013e3282ee2aa8","article-title":"The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior","volume":"18","author":"Schmidt","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.expneurol.2007.10.015_bib52","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature02553","article-title":"Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus","volume":"429","author":"Schmidt-Hieber","year":"2004","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.expneurol.2007.10.015_bib53","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","article-title":"Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism","volume":"24","author":"Spires","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.expneurol.2007.10.015_bib54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet"},{"key":"10.1016\/j.expneurol.2007.10.015_bib55","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1017\/S109285290002201X","article-title":"Depression and Huntington's disease: prevelance, clinical manifestations, etiology, and treatment","volume":"6","author":"Slaughter","year":"2001","journal-title":"CNS Spectr"},{"issue":"1","key":"10.1016\/j.expneurol.2007.10.015_bib56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1124\/pr.58.1.7","article-title":"Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview","volume":"58","author":"Tardito","year":"2006","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.expneurol.2007.10.015_bib57","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0169-328X(98)00173-9","article-title":"Changes in proliferating cell nuclear antigen, a protein involved in DNA repair, in vulnerable hippocampal neurons following global cerebral ischemia","volume":"60","author":"Tomasevic","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"issue":"6","key":"10.1016\/j.expneurol.2007.10.015_bib58","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.expneurol.2007.10.015_bib59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.expneurol.2007.10.015_bib60","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0149-06.2006","article-title":"Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum","volume":"26","author":"Yamashita","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.expneurol.2007.10.015_bib61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchromb.2005.01.027","article-title":"Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry","volume":"819","author":"Zhao","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"5-6","key":"10.1016\/j.expneurol.2007.10.015_bib62","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog Neurobiol"},{"issue":"5529","key":"10.1016\/j.expneurol.2007.10.015_bib63","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.expneurol.2007.10.015_bib64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488607003974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488607003974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T11:22:10Z","timestamp":1557055330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488607003974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0014488607003974"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2007.10.015","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}